Top Markets
Coin of the day
Zhejiang Hisun Pharmaceutical Co., Ltd. Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

600267
Rang in Aktien #6297
Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the... Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its portfolio includes both active pharmaceutical ingredients (APIs) and finished drug formulations. The company's extensive therapeutic focus spans oncology, cardiovascular health, infectious diseases, liver support, orthopedics, parasitic infections, and immunosuppression. Additionally, Hisun Pharmaceutical addresses conditions such as weight management, viral infections, tuberculosis, and offers veterinary pharmaceuticals, among other specialized medical applications. Beyond its product lines, the firm provides product consultation and contract manufacturing/research (CMO/CRO) services. Established in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is headquartered in Taizhou, China.
Aktienkurs
$1.79
Marktkapitalisierung
$2.12B
Veränderung (1 Tag)
0.65%
Veränderung (1 Jahr)
15.95%
Land
CN
Handel Zhejiang Hisun Pharmaceutical Co., Ltd. (600267)

Kategorie

Aktien-Split-Historie für Zhejiang Hisun Pharmaceutical Co., Ltd. (600267)
Die Aktie Zhejiang Hisun Pharmaceutical Co., Ltd. (Symbol: 600267) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 27, 2026 statt.
Eine 600267-Aktie, die vor dem Aug 27, 2026 gekauft wurde, entspricht heute 0 600267-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber